
Clinical Study Report Writing
The CSR is the document a regulator actually reads. We write full and abbreviated clinical study reports in ICH E3 format — clear, internally consistent, and structured exactly the way the reviewing agency expects.
Covered
Formats
Our Writers
Delivery
The Document Your Study Becomes
Every screening visit, blood draw, and statistical output of a clinical study eventually condenses into one document: the clinical study report. Written to ICH E3 — the internationally harmonised 16-section format — the CSR is what reviewers at the US FDA, EMA, and DCGI actually read to judge what your study showed and whether the data hold up.
Two CSRs can describe the same dataset and produce very different reviews. A strong report keeps every number consistent from synopsis to appendix, explains protocol deviations before the reviewer asks about them, and presents efficacy and safety findings in the order and depth the guideline prescribes. A weak one generates queries — and every query cycle costs submission time.
Our writers sit beside the clinical, pharmacokinetic, and biostatistics teams that generate the data, backed by a division that has executed 65+ studies. We deliver full ICH E3 reports for patient trials, abbreviated CSRs and BA/BE study reports, and standalone CSR writing from sponsor-provided data packages — each aligned to the target agency from the first draft.
The complete, structured account of a clinical study — its design, conduct, statistical analysis, and results — prepared for regulatory review. It is the primary evidence document an agency reads when deciding what a study demonstrated.
The ICH guideline "Structure and Content of Clinical Study Reports" — a harmonised 16-section format accepted by the US FDA, EMA, DCGI, and other major agencies, so reviewers can find methods, populations, efficacy, and safety in the same place in every submission.
The Major Sections of an ICH E3 Clinical Study Report
ICH E3 prescribes a numbered 16-section outline. This is where each part of your study lives in the final report.
| ICH E3 Section | What It Contains |
|---|---|
| 1–2 · Title Page & Synopsis | Study identifiers, sponsor details, and a standalone summary of design, methods, and key results |
| 5 · Ethics | Ethics committee approvals, ICH-GCP conduct statements, and informed consent procedures |
| 6 · Investigators & Study Structure | Who ran the study — investigators, sites, committees, and administrative responsibilities |
| 7–8 · Introduction & Objectives | Product background, development context, and the precise study objectives |
| 9 · Investigational Plan | Study design, endpoint definitions, treatments, blinding, randomization, and planned statistical methods |
| 10 · Study Patients | Participant disposition, protocol deviations, and analysis population definitions |
| 11 · Efficacy Evaluation | Datasets analysed, demographics and baseline data, and endpoint-by-endpoint efficacy results |
| 12 · Safety Evaluation | Extent of exposure, adverse events, deaths and serious events, laboratory values, and vital signs |
| 13–15 · Discussion, Tables & References | Overall conclusions, the cross-referenced summary tables and figures, and literature cited |
| 16 · Appendices | Protocol and amendments, sample CRF, randomization scheme, data listings, and supporting documents |
Where This Work Happens

CSR Writing Process
- 01
Scope & Source Package
Protocol, statistical analysis plan, tables-listings-figures, and target agency agreed — with the delivery timeline fixed against your database lock.
- 02
Shell & Synopsis
An ICH E3 shell tailored to the agency, with the synopsis drafted early so key messages are aligned before full writing begins.
- 03
First Full Draft
The complete report written from final outputs, with medical review for scientific accuracy and consistent interpretation.
- 04
Review Cycles & Data QC
Sponsor comments consolidated across rounds, and every in-text number checked against the source tables before each draft moves.
- 05
Finalisation & Submission Support
Appendices compiled, formatting made submission-ready, and the final CSR delivered with support through agency questions.
Why Sponsors Choose Us for CSR Writing
- Writers embedded with the clinical, PK, and biostatistics teams
- Full ICH E3, abbreviated, and BA/BE study report formats
- Backed by 70+ years of cumulative team experience
- Every in-text number QC-checked against source tables
- Structure and emphasis tailored to FDA, EMA, or DCGI review
- On-time delivery commitments agreed per document, and kept
CSR Writing — Frequently Asked Questions
1. What is ICH E3?
2. What are the main sections of a clinical study report?
3. How long does it take to write a clinical study report?
4. Is a full CSR required for bioequivalence studies?
5. What is the difference between a CSR and a journal manuscript?
6. Can you write a CSR from another CRO’s study data?
More Medical Writing Services
Every study type under one roof — explore the rest of our medical writing capabilities.
Discuss Your CSR Writing Requirement
Share your molecule and target market — our scientific team responds with a study design, timeline, and detailed proposal within 24 business hours.

